WallStSmart
PLSE

Pulse Biosciences Inc

NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$21.17
+4.75% today

Updated 2026-04-30

Market cap
$1.48B
P/E ratio
P/S ratio
4,240.58x
EPS (TTM)
$-1.08
Dividend yield
52W range
$13 – $26
Volume
0.3M

Pulse Biosciences Inc (PLSE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+4.3%
Last 4 quarters
Revenue YoY growth
-84.1%
Most recent quarter
EPS YoY growth
+42.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-11.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-19.5%
2026-02-20
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-20$-0.18+14.3%$25.08$20.19-19.5%
2025-10-29$-0.29+6.5%$17.35$16.90-2.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.21$-0.18+14.3%$264000.00-84.1%
2025-09-30$-0.31$-0.29+6.5%$86000.00
2025-06-30$-0.26$-0.28-7.7%
2025-03-31$-0.25$832000.00
2024-12-31$-0.24$-0.31-30.2%$1.66M-4.4%
2024-09-30$-0.24$-0.21+13.5%
2024-06-30$-0.20$-0.20+0.5%
2024-03-31$-0.24$-0.18+23.5%
2023-12-31$-0.24$-0.22+9.7%$1.74M
2023-09-30$-0.22$-0.19+13.6%
2023-06-30$-0.22$-0.22+0.0%
2023-03-31$-0.22$-0.26-18.2%

Frequently asked questions

Has Pulse Biosciences Inc beaten earnings estimates?
Pulse Biosciences Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +4.3% over the last 3 quarters.
How does PLSE stock react to earnings?
PLSE stock has moved an average of -11.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Pulse Biosciences Inc's revenue growth rate?
Pulse Biosciences Inc reported year-over-year revenue growth of -84.1% in its most recent quarter, with EPS growing +42.4% year-over-year.